Lanthanoid complexation by a tris-tetrazole-functionalised calix[4]arene
dc.contributor.author | D'Alessio, D | en_AU |
dc.contributor.author | Skelton, BW | en_AU |
dc.contributor.author | Sobolev, AN | en_AU |
dc.contributor.author | Krause-Heuer, AM | en_AU |
dc.contributor.author | Fraser, BH | en_AU |
dc.contributor.author | Massi, M | en_AU |
dc.contributor.author | Ogden, MI | en_AU |
dc.date.accessioned | 2021-08-11T05:20:09Z | en_AU |
dc.date.available | 2021-08-11T05:20:09Z | en_AU |
dc.date.issued | 2016-12-19 | en_AU |
dc.date.statistics | 2021-08-10 | en_AU |
dc.description.abstract | The synthesis and characterization of 5,11,17,23-tetra-tert-butyl-25-hydroxy-26,27,28-tris(tetrazol-5-ylmethoxy)calix[4]arene is reported. Purification of the macrocycle required the use of preparative HPLC techniques. The macrocycle was found to be a poorer ligand for complexation of lanthanoid cations than the bis(tetrazole) analogue, but somewhat more effective than the tetrakis(tetrazole)-substituted derivative. Two metal complexes of the tris(tetrazole)–calixarene were structurally characterised. A polymeric sodium salt of the tris(tetrazole)–calixarene was isolated from a solution containing yttrium and a sodium acetate buffer. A praseodymium complex was isolated in the presence of an ammonium acetate buffer, where the calixarene acts as a unidentate ligand, bound to the metal atom through one tetrazole N-atom. Increasing the amount of buffer resulted in the crystallisation of a metal-free ammonium salt of the calixarene. © 2016 John Wiley & Sons, Inc. | en_AU |
dc.identifier.citation | D'Alessio, D., Skelton, B. W., Sobolev, A. N., Krause-Heuer, A. M., Fraser, B. H., Massi, M., & Ogden, M. I. (2016). Lanthanoid complexation by a tris-tetrazole-functionalised calix[4]arene. European Journal of Inorganic Chemistry, 2016(34), 5366-5372. doi:10.1002/ejic.201600938 | en_AU |
dc.identifier.issn | 1434-1948 | en_AU |
dc.identifier.issue | 34 | en_AU |
dc.identifier.journaltitle | European Journal of Inorganic Chemistry | en_AU |
dc.identifier.pagination | 5366-5372 | en_AU |
dc.identifier.uri | https://doi.org/10.1002/ejic.201600938 | en_AU |
dc.identifier.uri | https://apo.ansto.gov.au/dspace/handle/10238/11327 | en_AU |
dc.identifier.volume | 2016 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | John Wiley & Sons, Inc | en_AU |
dc.subject | Rare earths | en_AU |
dc.subject | Complexes | en_AU |
dc.subject | Tetrazoles | en_AU |
dc.subject | Calixarenes | en_AU |
dc.subject | Purification | en_AU |
dc.subject | Ligands | en_AU |
dc.subject | Sodium | en_AU |
dc.subject | Ytterbium | en_AU |
dc.title | Lanthanoid complexation by a tris-tetrazole-functionalised calix[4]arene | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.63 KB
- Format:
- Item-specific license agreed upon to submission
- Description: